Journal of International Oncology ›› 2025, Vol. 52 ›› Issue (2): 107-112.doi: 10.3760/cma.j.cn371439-20240522-00016

• Review • Previous Articles     Next Articles

Mechanism of Breg cell in tumor immune escape and related therapeutic targets

Wang Xibo1,2, Tian Baowen3(), Chen Shiqiao4()   

  1. 1Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, China
    2Second Clinical Medicine School, Shandong University, Jinan 250033, China
    3Department of General Surgery (Hepatobiliary Surgery), Qilu Hospital of Shandong University, Jinan 250013, China
    4Department of Interventional Diagnosis and Treatment, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China
  • Received:2024-05-22 Revised:2024-06-04 Online:2025-02-08 Published:2025-03-17
  • Contact: Tian Baowen, Email: tianbaowen1113@163.com;Chen Shiqiao, Email: chenshiqiaoccu@163.com
  • Supported by:
    Natural Science Foundation of Shandong Province of China(ZR2021MH065);National College Innovation and Entrepreneurship Training Program(202310422024)

Abstract:

Tumor cells can escape the surveillance and attack of the immune system, namely immune escape. In recent years, regulatory B (Breg) cell have attracted much attention in researches about tumor immunity. Breg cell plays an important role in tumor immune escape by secreted various cytokines. Mechanistic progress has been made in this field, which provides more targets and ideas for tumor clinical treatment. However, the phenotypic classification of Breg cells and its complex mechanism in tumor immunity still need to be systematically analyzed.

Key words: B-lymphocytes, regulatory, Tumor microenvironment, Cytokines, T-lymphocytes, Immunotherapy